tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2021 Dec 13;9(12):1474.
doi: 10.3390/vaccines9121474.
COVID-19 Vaccination: The Mainspring of Challenges and the Seed of Remonstrance
Hoda Najjar[SUP] 1 [/SUP], Hadeel T Al-Jighefee[SUP] 1 2 [/SUP], Abeer Qush[SUP] 1 [/SUP], Muna Nizar Ahmed[SUP] 1 [/SUP], Sara Awwad[SUP] 1 [/SUP], Layla Kamareddine[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
As of March 2020, the time when the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic, our existence has been threatened and the lives of millions have been claimed. With this ongoing global issue, vaccines are considered of paramount importance in curtailing the outbreak and probably a prime gamble to bring us back to 'ordinary life'. To date, more than 200 vaccine candidates have been produced, many of which were approved by the Food and Drug Administration (FDA) for emergency use, with the research and discovery phase of their production process passed over. Capering such a chief practice in COVID-19 vaccine development, and manufacturing vaccines at an unprecedented speed brought many challenges into play and raised COVID-19 vaccine remonstrance. In this review, we highlight relevant challenges to global COVID-19 vaccine development, dissemination, and deployment, particularly at the level of large-scale production and distribution. We also delineate public perception on COVID-19 vaccination and outline the main facets affecting people's willingness to get vaccinated.
Keywords: COVID-19; SARS-CoV-2; challenges; distribution; production; public perception; remonstrance; safety; vaccination.
. 2021 Dec 13;9(12):1474.
doi: 10.3390/vaccines9121474.
COVID-19 Vaccination: The Mainspring of Challenges and the Seed of Remonstrance
Hoda Najjar[SUP] 1 [/SUP], Hadeel T Al-Jighefee[SUP] 1 2 [/SUP], Abeer Qush[SUP] 1 [/SUP], Muna Nizar Ahmed[SUP] 1 [/SUP], Sara Awwad[SUP] 1 [/SUP], Layla Kamareddine[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 34960220
- DOI: 10.3390/vaccines9121474
Abstract
As of March 2020, the time when the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic, our existence has been threatened and the lives of millions have been claimed. With this ongoing global issue, vaccines are considered of paramount importance in curtailing the outbreak and probably a prime gamble to bring us back to 'ordinary life'. To date, more than 200 vaccine candidates have been produced, many of which were approved by the Food and Drug Administration (FDA) for emergency use, with the research and discovery phase of their production process passed over. Capering such a chief practice in COVID-19 vaccine development, and manufacturing vaccines at an unprecedented speed brought many challenges into play and raised COVID-19 vaccine remonstrance. In this review, we highlight relevant challenges to global COVID-19 vaccine development, dissemination, and deployment, particularly at the level of large-scale production and distribution. We also delineate public perception on COVID-19 vaccination and outline the main facets affecting people's willingness to get vaccinated.
Keywords: COVID-19; SARS-CoV-2; challenges; distribution; production; public perception; remonstrance; safety; vaccination.